These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


125 related items for PubMed ID: 8840971

  • 1. Differential expression of psoriasin messenger RNA between in situ and invasive human breast carcinoma.
    Leygue E, Snell L, Hiller T, Dotzlaw H, Hole K, Murphy LC, Watson PH.
    Cancer Res; 1996 Oct 15; 56(20):4606-9. PubMed ID: 8840971
    [Abstract] [Full Text] [Related]

  • 2. Psoriasin expression in mammary epithelial cells in vitro and in vivo.
    Enerbäck C, Porter DA, Seth P, Sgroi D, Gaudet J, Weremowicz S, Morton CC, Schnitt S, Pitts RL, Stampl J, Barnhart K, Polyak K.
    Cancer Res; 2002 Jan 01; 62(1):43-7. PubMed ID: 11782356
    [Abstract] [Full Text] [Related]

  • 3. Evidence that molecular changes in cells occur before morphological alterations during the progression of breast ductal carcinoma.
    Castro NP, Osório CA, Torres C, Bastos EP, Mourão-Neto M, Soares FA, Brentani HP, Carraro DM.
    Breast Cancer Res; 2008 Jan 01; 10(5):R87. PubMed ID: 18928525
    [Abstract] [Full Text] [Related]

  • 4. Psoriasin (S100A7) expression is associated with poor outcome in estrogen receptor-negative invasive breast cancer.
    Emberley ED, Niu Y, Njue C, Kliewer EV, Murphy LC, Watson PH.
    Clin Cancer Res; 2003 Jul 01; 9(7):2627-31. PubMed ID: 12855640
    [Abstract] [Full Text] [Related]

  • 5. A putative role for psoriasin in breast tumor progression.
    Krop I, März A, Carlsson H, Li X, Bloushtain-Qimron N, Hu M, Gelman R, Sabel MS, Schnitt S, Ramaswamy S, Kleer CG, Enerbäck C, Polyak K.
    Cancer Res; 2005 Dec 15; 65(24):11326-34. PubMed ID: 16357139
    [Abstract] [Full Text] [Related]

  • 6. Increase of GKLF messenger RNA and protein expression during progression of breast cancer.
    Foster KW, Frost AR, McKie-Bell P, Lin CY, Engler JA, Grizzle WE, Ruppert JM.
    Cancer Res; 2000 Nov 15; 60(22):6488-95. PubMed ID: 11103818
    [Abstract] [Full Text] [Related]

  • 7. S100P calcium-binding protein overexpression is associated with immortalization of human breast epithelial cells in vitro and early stages of breast cancer development in vivo.
    Guerreiro Da Silva ID, Hu YF, Russo IH, Ao X, Salicioni AM, Yang X, Russo J.
    Int J Oncol; 2000 Feb 15; 16(2):231-40. PubMed ID: 10639564
    [Abstract] [Full Text] [Related]

  • 8. Changes in tenascin-C isoform expression in invasive and preinvasive breast disease.
    Adams M, Jones JL, Walker RA, Pringle JH, Bell SC.
    Cancer Res; 2002 Jun 01; 62(11):3289-97. PubMed ID: 12036947
    [Abstract] [Full Text] [Related]

  • 9. Progressive decrease in nuclear retinoic acid receptor beta messenger RNA level during breast carcinogenesis.
    Xu XC, Sneige N, Liu X, Nandagiri R, Lee JJ, Lukmanji F, Hortobagyi G, Lippman SM, Dhingra K, Lotan R.
    Cancer Res; 1997 Nov 15; 57(22):4992-6. PubMed ID: 9371489
    [Abstract] [Full Text] [Related]

  • 10. Id4 messenger RNA and estrogen receptor expression: inverse correlation in human normal breast epithelium and carcinoma.
    de Candia P, Akram M, Benezra R, Brogi E.
    Hum Pathol; 2006 Aug 15; 37(8):1032-41. PubMed ID: 16867866
    [Abstract] [Full Text] [Related]

  • 11. S100A7 (psoriasin) expression is associated with aggressive features and alteration of Jab1 in ductal carcinoma in situ of the breast.
    Emberley ED, Alowami S, Snell L, Murphy LC, Watson PH.
    Breast Cancer Res; 2004 Aug 15; 6(4):R308-15. PubMed ID: 15217497
    [Abstract] [Full Text] [Related]

  • 12. Loss of the tight junction protein claudin-7 correlates with histological grade in both ductal carcinoma in situ and invasive ductal carcinoma of the breast.
    Kominsky SL, Argani P, Korz D, Evron E, Raman V, Garrett E, Rein A, Sauter G, Kallioniemi OP, Sukumar S.
    Oncogene; 2003 Apr 03; 22(13):2021-33. PubMed ID: 12673207
    [Abstract] [Full Text] [Related]

  • 13. Progression-specific genes identified by expression profiling of matched ductal carcinomas in situ and invasive breast tumors, combining laser capture microdissection and oligonucleotide microarray analysis.
    Schuetz CS, Bonin M, Clare SE, Nieselt K, Sotlar K, Walter M, Fehm T, Solomayer E, Riess O, Wallwiener D, Kurek R, Neubauer HJ.
    Cancer Res; 2006 May 15; 66(10):5278-86. PubMed ID: 16707453
    [Abstract] [Full Text] [Related]

  • 14. Psoriasin interacts with Jab1 and influences breast cancer progression.
    Emberley ED, Niu Y, Leygue E, Tomes L, Gietz RD, Murphy LC, Watson PH.
    Cancer Res; 2003 Apr 15; 63(8):1954-61. PubMed ID: 12702588
    [Abstract] [Full Text] [Related]

  • 15. Similarity in expression of cell cycle proteins between in situ and invasive ductal breast lesions of same differentiation grade.
    Mommers EC, Leonhart AM, Falix F, Michalides R, Meijer CJ, Baak JP, Diest PJ.
    J Pathol; 2001 Jul 15; 194(3):327-33. PubMed ID: 11439365
    [Abstract] [Full Text] [Related]

  • 16. Vascular stroma formation in carcinoma in situ, invasive carcinoma, and metastatic carcinoma of the breast.
    Brown LF, Guidi AJ, Schnitt SJ, Van De Water L, Iruela-Arispe ML, Yeo TK, Tognazzi K, Dvorak HF.
    Clin Cancer Res; 1999 May 15; 5(5):1041-56. PubMed ID: 10353737
    [Abstract] [Full Text] [Related]

  • 17. Cyclooxygenase-2 expression in human breast cancers and adjacent ductal carcinoma in situ.
    Half E, Tang XM, Gwyn K, Sahin A, Wathen K, Sinicrope FA.
    Cancer Res; 2002 Mar 15; 62(6):1676-81. PubMed ID: 11912139
    [Abstract] [Full Text] [Related]

  • 18. S100A9 expression in invasive ductal carcinoma of the breast: S100A9 expression in adenocarcinoma is closely associated with poor tumour differentiation.
    Arai K, Teratani T, Kuruto-Niwa R, Yamada T, Nozawa R.
    Eur J Cancer; 2004 May 15; 40(8):1179-87. PubMed ID: 15110881
    [Abstract] [Full Text] [Related]

  • 19. Human telomerase reverse transcriptase mRNA is highly expressed in normal breast tissues and down-regulated in ductal carcinoma in situ.
    Liu J, Baykal A, Fung KM, Thompson-Lanza JA, Hoque A, Lippman SM, Sahin A.
    Int J Oncol; 2004 Apr 15; 24(4):879-84. PubMed ID: 15010825
    [Abstract] [Full Text] [Related]

  • 20. RET finger protein expression in invasive breast carcinoma: relationship between RFP and ErbB2 expression.
    Tezel GG, Uner A, Yildiz I, Guler G, Takahashi M.
    Pathol Res Pract; 2009 Apr 15; 205(6):403-8. PubMed ID: 19232840
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.